Ethnic Differences in Survival after Breast Cancer in South East Asia
Taib, Nur Aishah
Bulgiba, Awang M.
Verkooijen, Helena M.
MetadataShow full item record
CitationBhoo-Pathy, Nirmala, Mikael Hartman, Cheng-Har Yip, Nakul Saxena, Nur Aishah Taib, Siew-Eng Lim, Philip Iau, Hans-Olov Adami, Awang M. Bulgiba, Soo-Chin Lee, and Helena M. Verkooijen. 2012. Ethnic Differences in Survival after Breast Cancer in South East Asia. PLoS ONE 7(2): e30995.
AbstractBackground: The burden of breast cancer in Asia is escalating. We evaluated the impact of ethnicity on survival after breast cancer in the multi-ethnic region of South East Asia. Methodology/Principal Findings Using the Singapore-Malaysia hospital-based breast cancer registry, we analyzed the association between ethnicity and mortality following breast cancer in 5,264 patients diagnosed between 1990 and 2007 (Chinese: 71.6%, Malay: 18.4%, Indian: 10.0%). We compared survival rates between ethnic groups and calculated adjusted hazard ratios (HR) to estimate the independent effect of ethnicity on survival. Malays (n = 968) presented at a significantly younger age, with larger tumors, and at later stages than the Chinese and Indians. Malays were also more likely to have axillary lymph node metastasis at similar tumor sizes and to have hormone receptor negative and poorly differentiated tumors. Five year overall survival was highest in the Chinese women (75.8%; 95%CI: 74.4%–77.3%) followed by Indians (68.0%; 95%CI: 63.8%–72.2%), and Malays (58.5%; 95%CI: 55.2%–61.7%). Compared to the Chinese, Malay ethnicity was associated with significantly higher risk of all-cause mortality (HR: 1.34; 95%CI: 1.19–1.51), independent of age, stage, tumor characteristics and treatment. Indian ethnicity was not significantly associated with risk of mortality after breast cancer compared to the Chinese (HR: 1.14; 95%CI: 0.98–1.34). Conclusion: In South East Asia, Malay ethnicity is independently associated with poorer survival after breast cancer. Research into underlying reasons, potentially including variations in tumor biology, psychosocial factors, treatment responsiveness and lifestyle after diagnosis, is warranted.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8605303
- SPH Scholarly Articles